Tumor-specific killer cells in paraneoplastic cerebellar degeneration (original) (raw)

References

  1. Schuler, G. & Steinman, R.M. Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 186, 1183–1187 (1997).
    Article CAS Google Scholar
  2. Boon, T. & Old, L.J. Cancer tumor antigens. Curr. Opin. Immunol. 9, 681–683 (1997).
    Article CAS Google Scholar
  3. Darnell, R.B. Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity and the brain. Proc. Natl. Acad. Sci. USA 93, 4529–4536 (1996).
    Article CAS Google Scholar
  4. Furneaux, H.L., Reich, L. & Posner, J.P. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 40 , 1085–1091 (1990).
    Article CAS Google Scholar
  5. Dropcho, E., Chen, Y., Posner, J. & Old, L. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc. Natl. Acad. Sci. USA 84, 1–5 (1987).
    Article Google Scholar
  6. Fathallah-Shaykh, H., Wolf, S., Wong, E., Posner, J. & Furneaux, H. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc. Natl. Acad. Sci. USA 88, 3451– 3454 (1991).
    Article CAS Google Scholar
  7. Sakai, K., Mitchell, D.J., Tsukamoto, T. & Steinman, L. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal antibody from a patient with paraneoplastic cerebellar degeneration. Ann. Neurol. 28, 692– 698 (1990).
    Article CAS Google Scholar
  8. Corradi, J.P., Yang, C.W., Darnell, J.C., Dalmau, J. & Darnell, R.B. A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues. J. Neurosci. 17, 1406–1415 (1997).
    Article CAS Google Scholar
  9. Peterson, K., Rosenblum, M.K., Kotanides, H. & Posner, J.B. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42, 1931–1937 (1992).
    Article CAS Google Scholar
  10. Bender, A., Sapp, M., Schuler, G., Steinman, R.M. & Bhardwaj, N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196, 121–135 ( 1996).
    Article CAS Google Scholar
  11. Albert, M.L., Sauter, B. & Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I- restricted CTLs. Nature 392, 86–89 (1998).
    Article CAS Google Scholar
  12. Bennett, S.R. et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478–80 (1998).
    Article CAS Google Scholar
  13. Boon, T., Cerottini, J.C., Van den Eynde, B., van der Bruggen, P. & Van Pel, A. Tumor antigens recognized by T lymphocytes. Ann. Rev. Immunol. 12, 337–365 (1994).
    Article CAS Google Scholar
  14. Carmichael, A., Jin, X., Sissons, P. & Borysiewicz, L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease. J. Exp. Med. 177, 249–56 (1993).
    Article CAS Google Scholar
  15. Koup, R.A. et al. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J. Exp. Med. 174, 1593–1600 (1991).
    Article CAS Google Scholar
  16. McMichael, A. Cytotoxic T lymphocytes specific for influenza virus. Curr. Top. Microbiol. Immunol. 189, 75–91 (1994).
    CAS PubMed Google Scholar
  17. Darnell, R.B. & DeAngelis, L.M. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 341, 21–22 ( 1993).
    Article CAS Google Scholar
  18. Devita, V.T., Hellman, S. & Rosenberg, S. in Cancer, Principles and Practice of Oncology, 1930–1931 (J.B. Lippincott, Philadelphia, 1989).
    Google Scholar
  19. Huang, A.Y. et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264, 961–5 (1994).
    Article CAS Google Scholar
  20. Zitvogel, L. et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183, 87– 97 (1996).
    Article CAS Google Scholar
  21. Dalmau, J. et al. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 75, 99–109 (1995).
    Article CAS Google Scholar
  22. Strand, S. et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells—a mechanism of immune evasion? Nature Med. 2, 1361-1366 (1996).
    Article CAS Google Scholar
  23. Corriveau, R.A., Huh, G.S. & Shatz, C.J. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron 21, 1–20 (1998).
    Article Google Scholar
  24. Bhardwaj, N. et al. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J. Clin. Invest. 94, 797–807 (1994).
    Article CAS Google Scholar
  25. Barouch, D. et al. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J. Exp. Med. 182, 1847 –56 (1995).
    Article CAS Google Scholar

Download references